HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sendai virus-mediated gene transfer of the c-myc suppressor far-upstream element-binding protein-interacting repressor suppresses head and neck cancer.

Abstract
Far-upstream element-binding protein-interacting repressor (FIR) is a transcription factor that inhibits c-Myc expression and has been shown to have antitumor effects in some malignancies. Here, we evaluated the antitumor effects of FIR using fusion gene-deleted Sendai virus (SeV/ΔF) as a nontransmissible vector against head and neck squamous cell carcinoma (HNSCC). Using in vitro and in vivo xenograft mouse models, we observed efficient expression of green fluorescent protein (GFP) following transduction with the SeV/ΔF vector encoding GFP (GFP-SeV/ΔF) into HNSCC cells. In vitro and in vivo studies revealed that administration of the FIR-encoded SeV/ΔF (FIR-SeV/ΔF) vector exerted significant antitumor effects, suppressed c-Myc expression and induced apoptosis in HNSCC. Additionally, the antitumor effects of FIR or the expression of GFP following administration of the FIR- or GFP-SeV/ΔF vector, respectively, were dependent on the multiplicity of infection or titer. Furthermore, the SeV/ΔF vector itself had no cytotoxic effects. Therefore, the SeV/ΔF vector may be safe and useful for the treatment of HNSCC, allowing for high-titer SeV/ΔF vector administration for anticancer gene therapy. In addition, SeV/ΔF vector-mediated FIR gene therapy demonstrated effective tumor suppression in HNSCC, suggesting that this therapy may have the potential for clinical use as a novel strategy for HNSCC treatment.
AuthorsN Tanaka, K Araki, D Mizokami, Y Miyagawa, T Yamashita, M Tomifuji, Y Ueda, M Inoue, K Matsushita, F Nomura, H Shimada, A Shiotani
JournalGene therapy (Gene Ther) Vol. 22 Issue 4 Pg. 297-304 (Apr 2015) ISSN: 1476-5462 [Electronic] England
PMID25588744 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • FARP2 protein, human
  • Guanine Nucleotide Exchange Factors
  • MYC protein, human
  • Proto-Oncogene Proteins c-myc
Topics
  • Animals
  • Cell Line
  • Female
  • Gene Transfer Techniques
  • Genetic Therapy
  • Genetic Vectors
  • Guanine Nucleotide Exchange Factors (metabolism)
  • Head and Neck Neoplasms (genetics, metabolism, therapy)
  • Heterografts
  • Humans
  • Mice
  • Neoplasm Transplantation
  • Proto-Oncogene Proteins c-myc (metabolism)
  • Sendai virus (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: